These factors are present in the tumor microenvironment not only because many human tumors produce them but also because activated iTreg, the subtype of Treg accumulating in tissues and the peripheral circulation of cancer patients, are also ADO and PGE2 producers. This evidence concerns the gene ADO and cancer.